European public procurement and grants data from official registers · Data as of 18 November 2026; updated daily.

Tenders

Medical and healthcare tenders in Stuttgart

Medical and healthcare tenders in Stuttgart: 196 listed on GranTender since 2024; 1 open now. The median awarded contract value is about €220,000 (223 contracts with a stated value). Buyers with the most tenders: AOK Baden-Württemberg (127), Postbeamtenkrankenkasse (9) and University of Stuttgart (8); suppliers with the most contract awards: Aliud Pharma GmbH (19), Hexal AG (17) and ratiopharm GmbH (15). Sources: oeffentlichevergabe.de and TED. In 2025 the median contract value was €220,000; 6% of contracts drew a single bid (4.7 bids on average). Data as of 18 November 2026; updated daily.

Tenders
196
Open tenders
1
Awards
511
Awarded value awarded
€107,100,145
Awarded value framework ceiling
€77,857,980
Median contract value awarded
≈ €220,000
Median contract value framework ceiling
≈ €220,000
Average bids per contract
5.0
Tenders in 2025
68 -8% on 2024

Median: contracts with a stated value, rounded. Average bids: contracts where the number of bids is published.

Value kinds: awarded — the value in the award decision; contract — the value of the signed or amended contract; paid — the amount actually paid; framework ceiling — the maximum of a framework agreement, given with every winner, not money spent. Different kinds are never added together.

Open tenders

Latest tenders

TenderBuyerEstimated valueStatusPublished
Dienstleister für Arbeitsschutz für das Staatsministerium Baden-WürttembergLand Baden-Württemberg vertreten durch das Staatsministerium Baden-Württemberg—Open29 October 2026
Arzneimittelrabattvereinbarung gemäß § 130c Abs. 1 SGB V i. V. m § 130a Abs. 8 SGB V zur Wirkstoffkombination Vilanterol und UmeclidiniumbromidAOK Baden-Württemberg—Awarded29 October 2026
Arzneimittelrabattvereinbarung gemäß § 130c Abs. 1 SGB V i. V. m § 130a Abs. 8 SGB V zum Wirkstoff TezepelumabAOK Baden-Württemberg—Awarded9 October 2026
Arzneimittelrabattvereinbarung gemäß § 130c Abs. 1 SGB V i. V. m § 130a Abs. 8 SGB V zum Wirkstoff RavulizumabAOK Baden-Württemberg—Awarded30 September 2026
Arzneimittelrabattvereinbarung gemäß § 130c Abs. 1 SGB V i. V. m § 130a Abs. 8 SGB V zum Wirkstoff CrovalimabAOK Baden-Württemberg—Awarded30 September 2026
Arzneimittelrabattvereinbarung gemäß § 130a Abs. 8 SGB V zu dem Wirkstoff Concizumab (Alhemo®)AOK Baden-Württemberg€216,000Awarded29 September 2026
Vereinbarung gemäß § 130c Abs. 1 SGB V über die Gewährung von Rabatten für patentgeschützte Arzneimittel mit dem Wirkstoff Eftrenonacog alfa (Alprolix®)AOK Baden-Württemberg—Awarded29 September 2026
Vereinbarung gemäß § 130a Abs. 8 SGB V über die Gewährung von Rabatten für die Arzneimittel mit den Wirkstoffen Blutgerinnungsfaktor VIII (human) sowie von Willebrand-Faktor und Blutgerinnungsfaktor VIII (human) in KombinationAOK Baden-Württemberg—Awarded29 September 2026
Vereinbarung gemäß § 130c Abs. 1 SGB V über die Gewährung von Rabatten für patentgeschützte Arzneimittel mit den Wirkstoffen Turoctocog alfa (NovoEight®) und Turoctocog alfa pegol (Esperoct®).AOK Baden-Württemberg—Awarded29 September 2026
Vereinbarung gemäß § 130c Abs. 1 SGB V über die Gewährung von Rabatten für patentgeschützte Arzneimittel mit den Wirkstoffen Lonoctocog alfa (Afstyla®) und Albutrepenonacog alfa (Idelvion®)AOK Baden-Württemberg—Awarded29 September 2026
Arzneimittelrabattvereinbarung nach § 130a Abs. 8 SGB V zu den Wirkstoffen Wirkstoffen Blutgerinnungsfaktor VII, IX, Simoctocog alfa sowie von Willebrand-Faktor und Blutgerinnungsfaktor VIII in KombinationAOK Baden-Württemberg€216,000Awarded29 September 2026
Arzneimittelrabattvereinbarung nach § 130a Abs. 8 SGB V zu dem Wirkstoff Blutgerinnungsfaktor VIII (human) (Fanhdi®)AOK Baden-Württemberg€216,000Awarded29 September 2026
Arzneimittelrabattvereinbarung gemäß § 130a Abs. 8 SGB V zu den Wirkstoffen Blutgerinnungsfaktor VIII (human) sowie Blutgerinnungsfaktor IX (human)AOK Baden-Württemberg—Awarded29 September 2026
Arzneimittelrabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Efmoroctocog alfa sowie zum Wirkstoff Efanesoctocog alfaAOK Baden-Württemberg€216,000Awarded29 September 2026
Arzneimittelrabattvereinbarung gemäß § 130a Abs. 8 SGB V zu den Wirkstoffen Wirkstoffen Moroctocog alfa (Refacto®) und Nonacog alfa (Benefix®)AOK Baden-Württemberg€216,000Awarded29 September 2026
Arzneimittelrabattvereinbarung nach § 130a Abs. 8 SGB V über 9 Präparate zur Behandlung der HämophilieAOK Baden-Württemberg€216,000Awarded29 September 2026
Arzneimittelrabattvereinbarung gemäß § 130a Abs. 8 SGB V zu dem Wirkstoff Blutgerinnungsfaktor VIII (human) (FAKTOR VIII SDH Intersero®)AOK Baden-Württemberg€216,000Awarded29 September 2026
Arzneimittelrabattvereinbarung gemäß § 130a Abs. 8 SGB V zu den Wirkstoffen Damoctocog alfa pegol und Octocog alfaAOK Baden-Württemberg€216,000Awarded29 September 2026
Arzneimittelrabattvereinbarung gemäß § 130c Abs. 1 SGB V i. V. m § 130a Abs. 8 SGB V zum Wirkstoff ErenumabAOK Baden-Württemberg—Awarded28 August 2026
Arbeitsmedizinische und sicherheitstechnische Betreuung für das Ministerium für Verkehr Baden-WürttembergLand Baden-Württemberg vertreten durch das Ministerium für Verkehr Baden-Württemberg—Closed21 August 2026

Competition and prices

In 2025, half of the contracts were worth between €220,000 and €220,000, with a median of €220,000 (98 contracts with a stated awarded value). Contracts drew 4.7 bids on average (median 4) and 6% drew a single bid — based on 86 contracts with a known number of bids. Compared with 2024, in 2025 the share of single-bid contracts fell from 14% to 6%. The usual procedures: open procedure (60%), negotiation without a call for competition (31%), negotiated procedure (7%) — of 191 tenders with a stated procedure.

The most contracts went to Aliud Pharma GmbH (19), Hexal AG (17) and ratiopharm GmbH (15) — together 10% of all contracts.

YearContractsMedian valueMiddle half of valuesBids on averageSingle bid
2024212€220,000€220,000 – €220,0004.714% (139)
2025184€220,000€220,000 – €220,0004.76% (86)
2026 (so far)111——5.88% (79)
All years511€220,000€220,000 – €220,0005.010% (305)

Values: contracts with a stated value in EUR, each value kind on its own (awarded or contract value), approximate (±3 %). Bids: contracts of procedures with competition whose number of bids the source publishes (1–100 bids); the sources publish it for some contracts only (TED ≈ 3 in 4, Spain all, Poland about half, Italy few), so each figure states its base and is shown from 20 contracts. A contract counts in the year of its award (else of its tender). Figures as of 13 November 2026, recomputed every week.

Main CPV divisions

Sectors in Stuttgart

Topics in Stuttgart

Other cities in Baden-Württemberg

Questions and answers

Which medical and healthcare tenders in Stuttgart are open now?
1 of the 196 medical and healthcare tenders in Stuttgart listed on GranTender is open for bids. For example: Dienstleister für Arbeitsschutz für das Staatsministerium Baden-Württemberg.
Where can I find medical and healthcare tenders in Stuttgart?
GranTender lists them in one place, from oeffentlichevergabe.de and TED, with their buyers, winners and contract values; 1 is open now. Search in one country at a time (the first 5 results) is free; search across all countries at once, full result lists, saved keywords with an e-mail once a week and exports come with a plan.
Who wins the most medical and healthcare tenders in Stuttgart?
By number of contracts won: Aliud Pharma GmbH (19), Hexal AG (17), ratiopharm GmbH (15).
Which buyers publish the most medical and healthcare tenders in Stuttgart?
By number of tenders: AOK Baden-Württemberg (127), Postbeamtenkrankenkasse (9), University of Stuttgart (8).
How many bids do medical and healthcare tenders in Stuttgart receive on average?
In 2025, contracts drew 4.7 bids on average (median 4) and 6% drew a single bid — based on 86 contracts with a known number of bids.
How much are contracts for medical and healthcare tenders in Stuttgart worth?
In 2025, half of the contracts were worth between €220,000 and €220,000, with a median of €220,000 (98 contracts with a stated awarded value). Compared with 2024, in 2025 the share of single-bid contracts fell from 14% to 6%.
Which procedures are used for medical and healthcare tenders in Stuttgart?
The usual procedures: open procedure (60%), negotiation without a call for competition (31%), negotiated procedure (7%) — of 191 tenders with a stated procedure.

A tender belongs to the city of its buyer, else to the city of its place of performance; an entry of a contract register without a place is assigned to its buyer's city. City names: Cities: GeoNames, CC BY 4.0.